期刊
CANCER MANAGEMENT AND RESEARCH
卷 13, 期 -, 页码 359-366出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/CMAR.S287152
关键词
SARS-CoV-2; COVID-19; ovarian cancer management; pandemic; cancer care delay
类别
资金
- National Institutes of Health/National Cancer Institute [CA204801, CA231925]
- University of South Alabama Mitchell Cancer Institute
The COVID-19 pandemic has had a significant impact on the diagnosis and treatment of ovarian cancer patients, leading to higher levels of cancer worry, anxiety, and depression. This article succinctly reviews the effects of COVID-19 on OC patients and discusses alternative therapeutic strategies to reduce in-person hospital visits and limit disease spread.
COVID-19, also known as the coronavirus disease 2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) declared pandemic by the World Health Organization (WHO). As the world faces the coronavirus disease 2019 crisis, the oncology community is being impacted by unprecedented challenges. During this trying time, patients with ovarian cancer (OC) have been affected by a delay in diagnosis, surgery, chemotherapy and radiation treatments, and oncology follow-ups being conducted via telemedicine instead of in-person visits. OC patients and their oncologists are balancing the fears of COVID-19 and cancer treatment with the consequences of delaying cancer care. The delay in treatment care that women with OC are experiencing has resulted in higher levels of cancer worry, anxiety, and depression. In this article, we succinctly review the impact of the COVID-19 pandemic on the diagnosis and treatment and ongoing clinical trials of OC. We also discuss the psychological effects of COVID-19 on women with OC and alternative therapeutic strategies to limit in-person hospital visits to reduce the spread of the disease, and the impact of COVID-19 on OC patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据